Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial. (Q51908211)
Jump to navigation
Jump to search
scientific article published on 8 January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial. |
scientific article published on 8 January 2007 |
Statements
1 reference
Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial. (English)
1 reference
Abraham Weizman
1 reference
Rael D Strous
1 reference
Rafael Stryjer
1 reference
Rachel Maayan
1 reference
Gilad Gal
1 reference
Dina Viglin
1 reference
Elena Katz
1 reference
Dana Eisner
1 reference
8 January 2007
1 reference
32
1 reference
96-105
1 reference
2
1 reference
Identifiers
1 reference